USD 152.2 million
Report ID:
SQMIG35A2560 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
65
|Figures:
75
Preterm Birth Diagnostic Test Kits Market size was valued at USD 152.2 million in 2023 and is poised to grow from USD 163.77 million in 2024 to USD 294.26 million by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).
The Global Preterm Birth Diagnostic Test Kits market is driven by the rising prevalence of preterm births and the need for early detection.
These kits offer efficient and timely assessment of potential preterm births by analyzing biomarkers and clinical indicators.
Growing awareness among healthcare providers and expecting mothers, coupled with advancements in diagnostic technologies, fuels market expansion.
North America and Europe hold significant market shares due to robust healthcare infrastructure.
However, Asia-Pacific displays promising growth due to increasing healthcare expenditure and awareness.
Continuous research and innovation in test kit development further enhance market prospects, aiming to reduce the global burden of preterm births.
Point-of-care testing refers to diagnostic tests that can be conducted near the patient, often at the bedside or in outpatient settings, providing rapid results.
In the preterm birth diagnostic test kits market, an increasing emphasis on point-of-care testing could lead to quicker assessments of preterm birth risk, enabling healthcare providers to make timely decisions and interventions.
This trend could be especially important in regions with limited access to advanced healthcare facilities.
US Preterm Birth Diagnostic Test Kits Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 152.2 million
Largest Segment
biochemical tests
Fastest Growth
biochemical tests
Growth Rate
7.6% CAGR
To get more reports on the above market click here to Buy The Report
Global Preterm Birth Diagnostic Test Kits Market is segmented by Test Type, Sample Type, End User and region. Based on Test Type, the market is segmented into Fetal Fibronectin (fFN) Test Kits, Placental Alpha Microglobulin-1 (PAMG-1) Test Kits and Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits. Based on Sample Type, the market is segmented into Blood Sample, Urine Sample and Vaginal Discharge Sample. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The cervical length measurement test, along with the fetal fibronectin test, were among the commonly used diagnostic tests for assessing the risk of preterm birth. These tests have been widely adopted and integrated into prenatal care to monitor and manage women at risk.
Advances in molecular biology and genetic testing techniques were driving innovation in the field of prenatal diagnostics. Genetic testing to identify genetic markers or variations associated with preterm birth risk was an area of growing interest. This segment was expected to grow as research identified more genetic factors contributing to preterm birth.
The largest end-user segment for preterm birth diagnostic test kits is often hospitals and clinics. This is because these healthcare facilities handle a significant portion of prenatal care and are well-equipped to perform various tests, including those related to preterm birth risk assessment. They serve a wide range of patients and are often the first point of contact for pregnant women seeking medical advice.
The fastest-growing segment could be homecare settings. Advancements in technology and the development of user-friendly test kits could make it easier for pregnant women to monitor their own condition from the comfort of their homes. This trend aligns with the broader shift towards personalized healthcare and patient empowerment.
To get detailed analysis on other segments, Request For Free Sample Report
North America, particularly the United States, has been a significant player in the medical device and diagnostics markets. The region's advanced healthcare infrastructure, research facilities, and high awareness of prenatal care contribute to a substantial market share in preterm birth diagnostic test kits. European countries also have advanced healthcare systems and a strong focus on maternal and fetal health. Countries like the United Kingdom, Germany, France, and the Nordic countries often drive demand for diagnostic tests related to preterm birth.
The Asia-Pacific region has seen rapid economic growth and increasing awareness about prenatal healthcare. Countries like China, India, and Japan have large populations and improving healthcare systems, which could contribute to growth in demand for preterm birth diagnostic test kits.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Preterm Birth Rates
Advancements in Medical Technology
Regulatory Challenges
High Costs and Limited Accessibility
Request Free Customization of this report to help us to meet your business objectives.
The global preterm birth diagnostic test kits market features a dynamic landscape with key players vying for market dominance. Established companies like ABC Diagnostics and XYZ Biotech compete based on innovation, accuracy, and user-friendliness of their diagnostic kits. Meanwhile, emerging players such as Innovate MedTech bring novel technologies to the forefront. Collaborations with research institutions and healthcare providers are pivotal strategies to expand market presence. Evolving regulations and increasing R&D investments drive competition, focusing on enhancing predictive capabilities and early detection, ultimately aiming to address the global health concern of preterm birth through advanced diagnostic solutions.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global preterm birth diagnostic test kits market is poised for promising growth, driven by increasing awareness and prioritization of maternal and infant health. Advances in medical technology and research are likely to result in more accurate and accessible diagnostic tools. Additionally, collaborations between healthcare institutions and industry players will aid in developing innovative solutions. With a focus on early detection and prevention, the market's future holds potential for improved preterm birth risk assessment, ultimately leading to reduced preterm birth rates and better outcomes for both mothers and infants.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 152.2 million |
Market size value in 2032 | USD 294.26 million |
Growth Rate | 7.6% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Preterm Birth Diagnostic Test Kits Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Preterm Birth Diagnostic Test Kits Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Preterm Birth Diagnostic Test Kits Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Preterm Birth Diagnostic Test Kits Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Preterm Birth Diagnostic Test Kits Market size was valued at USD 145.4 Million in 2023 and is poised to grow from USD 156.1 Million in 2024 to USD 257.4 Million by 2032, growing at a CAGR of 0.074 during the forecast period (2025-2032).
The global preterm birth diagnostic test kits market features a dynamic landscape with key players vying for market dominance. Established companies like ABC Diagnostics and XYZ Biotech compete based on innovation, accuracy, and user-friendliness of their diagnostic kits. Meanwhile, emerging players such as Innovate MedTech bring novel technologies to the forefront. Collaborations with research institutions and healthcare providers are pivotal strategies to expand market presence. Evolving regulations and increasing R&D investments drive competition, focusing on enhancing predictive capabilities and early detection, ultimately aiming to address the global health concern of preterm birth through advanced diagnostic solutions. 'Roche Diagnostics (Switzerland)', 'Abbott Laboratories (USA)', 'Siemens Healthineers (Germany)', 'Thermo Fisher Scientific (USA)', 'BD (Becton, Dickinson and Company) (USA)', 'PerkinElmer (USA)', 'bioMérieux (France)', 'Hologic, Inc. (USA)', 'Qiagen (Netherlands)', 'Danaher Corporation (USA)', 'Cepheid (USA)', 'Illumina, Inc. (USA)', 'Sysmex Corporation (Japan)', 'Agilent Technologies (USA)', 'Bio-Rad Laboratories (USA)', 'GenMark Diagnostics (USA)', 'Luminex Corporation (USA)', 'Randox Laboratories (United Kingdom)', 'NanoString Technologies (USA)', 'Myriad Genetics (USA)'
Preterm birth, defined as childbirth before 37 weeks of pregnancy, is a significant global health concern. The increasing incidence of preterm births drives the demand for accurate and reliable diagnostic test kits to identify and predict preterm labor. This driver is likely to persist as healthcare providers and governments focus on reducing preterm birth rates and improving maternal and neonatal health outcomes.
Advancements in Diagnostic Technologies: The preterm birth diagnostic test kits market has likely seen advancements in diagnostic technologies. This could include the development of more accurate and reliable tests that help healthcare professionals predict preterm birth risk with greater precision. These advancements might involve the integration of various biomarkers, genetic testing, proteomics, and other innovative approaches to enhance the sensitivity and specificity of diagnostic tests.
North America, particularly the United States, has been a significant player in the medical device and diagnostics markets. The region's advanced healthcare infrastructure, research facilities, and high awareness of prenatal care contribute to a substantial market share in preterm birth diagnostic test kits. European countries also have advanced healthcare systems and a strong focus on maternal and fetal health. Countries like the United Kingdom, Germany, France, and the Nordic countries often drive demand for diagnostic tests related to preterm birth.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2560
[email protected]
USA +1 351-333-4748